C12N 2770/24251
Methods of production or purification of viral material
C12N2770/24251 (Methods of production or purification of viral material) appears on 46 US grants and 82 published applications in this corpus.
Search patents in C12N- Granted patents
- 46
- Published applications
- 82
- Assignees
- 72
- Inventors
- 186
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 4 |
| 2006 | 0 | 4 |
| 2007 | 2 | 3 |
| 2008 | 2 | 3 |
| 2009 | 3 | 5 |
| 2010 | 4 | 10 |
| 2011 | 1 | 6 |
| 2012 | 3 | 6 |
| 2013 | 3 | 7 |
| 2014 | 2 | 5 |
| 2015 | 3 | 8 |
| 2016 | 4 | 2 |
| 2017 | 1 | 2 |
| 2018 | 4 | 2 |
| 2019 | 3 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 1 | 3 |
| 2025 | 2 | 1 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Immunogenic compositions of hepatitis c virus and uses thereof14 Apr 2026US 12,599,661 B2
- Method of purifying whole virus particles16 Dec 2025US 12,497,598 B2Hvidovre Hospital
- Compositions and methods for internal controls of microvesicle isolations25 Mar 2025US 12,258,587 B2Exosome Diagnostics, Inc.
- Efficient cell culture system for hepatitis C virus genotype 6A1 Oct 2024US 12,104,176 B2Hvidovre Hospital
- Optimized HCV full-length infectious cell culture systems and applications thereof7 May 2019US 10,280,404 B2Hvidovre Hospital
- High-yield genotype 1a, 2a and 3a hcv10 Sep 2026US 2026/0263580 A1Hvidovre Hospital
- Human broadly neutralizing monoclonal antibodies associated with hepatitisc virus clearance10 Sep 2026US 2026/0265351 A1The Johns Hopkins University
- Vsv vector-encoded hcv envelope proteins e1/e2 as vaccines against hepatitis c virus15 Jan 2026US 2026/0015593 A1Twincore Zentrum FüR Experimentelle Und Klinische Infektionsforschung GmbH
- Self-cleaving polyproteins and uses thereof6 Nov 2025US 2025/0339512 A1The University of Melbourne
- Efficient cell culture system for hepatitis c virus genotype 4a3 Oct 2024US 2024/0327801 A1Hvidovre Hospital
Most cited
By later US patents
- Method for the preparation of purified HCV RNA by exosome separation54US 7,198,923 B1Novartis Vaccines and Diagnostics, Inc. · 2007
- Method for purifying viral nucleic acids17US 5,958,677 ANew York Blood Center, Inc. · 1999
- Preparation of purified exosomes comprising HCV RNA15US 7,807,438 B2Novartis AG · 2010
- Replication of hepatitis C virus genome and identification of virus having high infectivity12US 5,552,310 A1996
- Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof8US 7,674,612 B2The Rockefeller University · 2010